M8377

α-Methyl-DL-tryptophan

≥98% (TLC), suitable for cell culture

Manufacturer: Sigma Aldrich

CAS Number: 153-91-3

Synonym(S): α-methyl-tryptophan

Select a Size

Pack Size SKU Availability Price
100 MG M8377-100-MG In Stock ₹ 4,578.98
250 MG M8377-250-MG In Stock ₹ 9,277.03
1 G M8377-1-G In Stock ₹ 25,189.78

M8377 - 100 MG

₹ 4,578.98

In Stock

Quantity

1

Base Price: ₹ 4,578.98

GST (18%): ₹ 824.216

Total Price: ₹ 5,403.196

product name

α-Methyl-DL-tryptophan, crystalline

Assay

≥98% (TLC)

Quality Level

200

form

crystalline

technique(s)

tissue culture: suitable

color

light yellow

storage temp.

2-8°C

SMILES string

CC(N)(Cc1c[nH]c2ccccc12)C(O)=O

InChI

1S/C12H14N2O2/c1-12(13,11(15)16)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,14H,6,13H2,1H3,(H,15,16)

InChI key

ZTTWHZHBPDYSQB-UHFFFAOYSA-N

Other Options

Image Product Name Manufacturer Price Range
α-Methyl-DL-tryptophan
-- ₹ 15,828.60 - ₹ 80,854.20

Related Products

Img

Sigma Aldrich

M3529

≥98% (TLC), suitable for ligand bin...

Img

Sigma Aldrich

M4139

>98% (TLC), suitable for cell cultu...

Img

Sigma Aldrich

O4000

≥95% (HPLC)...

Img

Sigma Aldrich

M3664

--

Img

Sigma Aldrich

L8753

≥98%, suitable for ligand binding a...

Img

Sigma Aldrich

P5267

≥99% (TLC), suitable for ligand bin...

Description

  • Application: Nanoengineered sonosensitive platelets for synergistically augmented sonodynamic tumor therapy by glutamine deprivation and cascading thrombosis.: This study explores the use of a-Methyl-DL-tryptophan in enhancing sonodynamic tumor therapy through the deprivation of glutamine and inducing thrombosis, offering a new approach to cancer treatment (Zhou et al., 2023).Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.: This article describes the application of a-Methyl-DL-tryptophan in developing transporter-targeted prodrugs, enhancing drug delivery systems, particularly in ocular treatments (Vooturi et al., 2012).SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.: The study investigates the role of a-Methyl-DL-tryptophan in targeting SLC6A14 for treating estrogen receptor-positive breast cancer, highlighting its potential as a therapeutic agent (Karunakaran et al., 2011).
  • Biochem/physiol Actions: α-methyl-DL-tryptophan is a blocker of ATBo, an amino acid transporter whose expression is upregulated in cancer.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves